Home › Dermatite atopica (eczema) › Alabama › Birmingham
Studi clinici su Dermatite atopica (eczema) a Birmingham, AL
9 studi su Dermatite atopica (eczema) cercano partecipanti presso sedi a Birmingham e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
In reclutamentoStudio osservazionale
- Cahaba Dermatology & Skin Health Center- Site Number : 8400006, Birmingham
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
In reclutamentoFase 2
- Novartis Investigative Site, Birmingham
- Novartis Investigative Site, Birmingham
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
In reclutamentoFase 2
- Enveda Investigative Site, Birmingham
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
In reclutamentoFase 1Volontari sani benvenuti
- Cahaba Dermatology & Skin Health Center, LLC, Birmingham
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
In reclutamentoFase 3
- Cahaba Dermatology & Skin Health Center, Birmingham
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
In reclutamentoFase 2
- AllerVie Clinical Research, Birmingham
- Cahaba Dermatology and Skin Health Center, Birmingham
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
In reclutamentoFase 3
- Leo Pharma Investigational site, Birmingham
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
In reclutamentoFase 3
- Cahaba Dermatology & Skin Health Center /ID# 263855, Birmingham
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
In reclutamentoFase 2
- Allervie Clinical Research, Birmingham
Studi su Dermatite atopica (eczema) in altre città
- New York City, NY13 studi
- Washington, DC11 studi
- Los Angeles, CA11 studi
- San Diego, CA10 studi
- San Antonio, TX10 studi
- Miami, FL9 studi
- Troy, MI8 studi
- Huntington Beach, CA8 studi
- Dallas, TX8 studi
- Sacramento, CA8 studi
- Tampa, FL7 studi
- Indianapolis, IN7 studi
Altri studi a Birmingham
- Cancro (tutti i tipi)30 studi
- Cancro al seno24 studi
- Obesità23 studi
- Cancro ovarico23 studi
- Cancro del polmone non a piccole cellule22 studi
- Leucemia mieloide acuta21 studi
- Mieloma multiplo18 studi
- BPCO17 studi
- Malattie cardiovascolari17 studi
- Sovrappeso16 studi
- Cancro dell'endometrio16 studi
- Diabete di tipo 216 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.